Current Roles

Employees:
38
Revenue:
$2.9M
About
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet need. We are advancing our pipeline in close partnership with the world-class translational engine at the University of Pennsylvania’s Gene Therapy Program. Using in vivo editing, our methods focus on inserting functioning genes into patients’ genomes, which offers long-term, stable expression of those genes. With our team’s proven track record, as well as the University of Pennsylvania’s deep expertise and translational genetic medicine engine, reversing the course of these devastating diseases is now within reach.
iECURE Address
1777 Sentry Parkway
Philadelphia, PA
United States
iECURE Email

Past Companies

iECURE, inc.Chief Medical Officer
Rosenau Family Research Foundation (formerly the Legacy of Angels Foundation)Executive Director
CEKQURES LLCFounder and President